The perceived effects of smoked cannabis on patients with multiple sclerosis (abst – 1997)  


Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain.   (abst – 1997) ed_treatments_for_neuropathic_and_multiple_sclerosis_related_pain


Analgesic effect of the cannabinoid analogue nabilone is not mediated by opioid receptors.          (abst – 1999)


Cannabinoid Receptor Messenger Rna Levels Decrease in a Subset of Neurons of the Lateral Striatum, Cortex and Hippocampus of Transgenic Huntington’s Disease Mice. (abst – 2000)


The synthetic cannabinoid WIN55,212-2 attenuates hyperalgesia and allodynia in a rat model of neuropathic pain                                                               (full – 2001)


The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids.                                                            (full – 2002)


Whether whole plant Cannabis extracts can improve intractable neurogenic symptoms? (full – 2003)                               


Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: Pain inhibition by receptors not present in the CNS                                                           (full – 2003)


Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial.  (full – 2003)


Randomised controlled trial of cannabis based medicinal extracts (CBME) in central neuropathic pain due to multiple sclerosis.                                                     (abst – 2003)


The effects of smoked cannabis in painful peripheral neuropathy and cancer pain refractory to opiods.    (abst – 2003)


New Compound That Acts On Peripheral Receptors May Be Promising Treatment For Some Nerve Pain (news – 2003)


Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 ‘N of 1’ studies            (full – 2004)                


Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial (full – 2004)


Are oral cannabinoids safe and effective in refractory neuropathic pain?              (abst – 2004)


Marijuana-like compounds may aid array of debiliating conditions ranging from Parkinson’s to pain         (news – 2004)


Ajulemic acid (IP-751): Synthesis, proof of principle, toxicity studies, and clinical trials (full – 2005)                             


Smoked cannabis therapy for HIV-related painful peripheral neuropathy: results of a randomized, placebo-controlled clinical trial.                                                  (abst – 2005)


Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis        (abst – 2005)                  


Effects of a Cannabinoid Agonist on Spinal Nociceptive Neurons in a Rodent Model of Neuropathic Pain         (full – 2006)                              


Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models    (full – 2006)                


Cannabinoids In Medicine: A Review Of Their Therapeutic Potential                  (full – 2006)


CB1 receptor selective activation inhibits beta-amyloid-induced iNOS protein expression in C6 cells and subsequently blunts tau protein hyperphosphorylation in co-cultured neurons.        (abst – 2006)                           


In MedPanel Summit, Leading Pain Experts Name Cannabinoids Among Most Promising Approaches to Treating Neuropathic Pain, Assert That Sociopolitical Climate Will Hamper Drug Approvals          (news – 2006)  oids_among_most/index.html?source=r_health


Endocannabinoid metabolism and uptake: novel targets for neuropathic and inflammatory pain   (full – 2007)         


The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3′- carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice. (full – 2007)                         


Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain            (full – 2007)


Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain.   (abst – 2007)           


Sativex successfully treats neuropathic pain characterised by allodynia: A randomised, double-blind, placebo-controlled clinical trial                                                    (abst – 2007)


Oromucosal delta9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: an uncontrolled, open-label, 2-year extension trial.

(abst – 2007)    


The synthetic cannabinoids attenuate allodynia and hyperalgesia in a rat model of trigeminal neuropathic pain.                                                           (abst – 2007)


Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo- controlled trial.            (abst – 2007)


The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors                                                   (abst – 2007)


Study Supports Medical Marijuana Use               (news – 2007)


Smoked Cannabis Reduces Foot Pain Associated With HIV In Placebo Trial (news – 2007)                             










Marijuana gives relief from chronic pain for AIDS sufferers               (news – 2007)


Cannabis may be safe and effective for HIV-related neuropathic pain             (news – 2007)


Marijuana, Very Efficient in Cutting Off HIV Related Nerve Pain             (news – 2007)   47003.shtml


Smoked Cannabis Proven Effective In Treating Neuropathic Pain            (news – 2007)


Selective Activation of Cannabinoid CB2 Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats (full – 2008)


Crucial Role of CB2 Cannabinoid Receptor in the Regulation of Central Immune Responses during Neuropathic Pain                                                                   (full – 2008)


MDA7: a novel selective agonist for CB2 receptors that prevents allodynia in rat neuropathic pain models.         (full – 2008)


Double Blind, Placebo Controlled Trial of Smoked Marijuana on Neuropathic Pain (full – 2008)                       


Comparison of analgesic effects and patient tolerability of nabilone and dihydrocodeine for chronic neuropathic pain: randomised, crossover, double blind study.                                                   (full – 2008)


Design and synthesis of a novel series of N-alkyl isatin acylhydrazone derivatives that act as selective cannabinoid receptor 2 agonists for the treatment of neuropathic pain.

(abst – 2008)     


Involvement of central cannabinoid CB2 receptor in reducing mechanical allodynia in a mouse model of neuropathic pain                                           (abst – 2008)


Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain.

(abst – 2008)      


Antihyperalgesic effect of a Cannabis sativa extract in a rat model of neuropathic pain: mechanisms involved.                                                 (abst – 2008)


Medicinal Marijuana Effective For Neuropathic Pain In HIV, Study Finds (news – 2008)                           


Marijuana May Be Effective For Neuropathic Pain                (news – 2008)


Tetrahydrocannabinol (Delta 9-THC) Treatment in Chronic Central Neuropathic Pain and Fibromyalgia Patients: Results of a Multicenter Survey                                                            (full – 2009)


Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain                                        (full – 2009)


Neuropathic Pain and Endocannabinoid-Degradation Blockade             (full – 2009)


Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain. (full – 2009)


Minocycline treatment inhibits microglial activation and alters spinal levels of endocannabinoids in a rat model of neuropathic pain                                                                         (full – 2009)


Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside. (full – 2009)                              


Beneficial effects of a Cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress.                                                  (abst – 2009)


Medical Marijuana and Peripheral Neuropathy                 (news – 2009)


Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain                                                        (full – 2010)


R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids    (full – 2010)                           


Pharmacological Treatment of Painful HIV-Associated Sensory Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials                                                             (full – 2010)


Smoked cannabis for chronic neuropathic pain: a randomized controlled trial (full – 2010)                          


Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain.      (full – 2010)                     


Misdiagnosed chronic pelvic pain: pudendal neuralgia responding to a novel use of palmitoylethanolamide.                                                      (abst – 2010)


An Open-Label Comparison of Nabilone and Gabapentin as Adjuvant Therapy or Monotherapy in the Management of Neuropathic Pain in Patients with Peripheral Neuropathy.        (abst – 2010)


Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study. (abst – 2010)                           


Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain.                                                      (abst – 2010)


Study Claims Cannabis Reduces Chronic Pain               (news – 2010)


Cannabinoids inhibit and may prevent neuropathic pain in diabetes.              (news – 2010)


Study: Smoking pot may ease chronic pain                (news – 2010)


Brief Report: Cannabidiol Prevents the Development of Cold and Mechanical Allodynia in Paclitaxel-Treated Female C57Bl6 Mice.                                                    (full – 2011)


Cannabinoid Agonists Inhibit Neuropathic Pain Induced by Brachial Plexus Avulsion in Mice by Affecting Glial Cells and MAP Kinases.                                                     (full – 2011)


Mutations in ABHD12 cause the neurodegenerative disease PHARC: An inborn error of endocannabinoid metabolism.                                            (full – 2011)


Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury.                                                        (abst – 2011)


Cannabinoids for Treatment of Chronic Non-Cancer Pain; a Systematic Review of Randomized Trials.   (abst – 2011)                          


Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.                                              (abst – 2011)  


Self-medication of a cannabinoid CB(2) agonist in an animal model of neuropathic pain. (abst – 2011)




Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain.                                                         (abst – 2011)


Cannabinoid ‘Completely’ Prevents Chemotherapy-Induced Neuropathy, Study Says (news – 2011)                          


Marijuana component may ease pain from chemo therapy drugs              (news – 2011)


Cannabidiol may help prevent paclitaxel-induced peripheral neuropathy             (news – 2011)  peripheral-neuropathy.aspx


Prescribing Cannabis for Harm Reduction.               (full – 2012)


The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB2 receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy                                                                                           (full – 2012)


Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series                                                       (full – 2012)


Dynamic changes to the endocannabinoid system in models of chronic pain (abst – 2012)                            


The atypical cannabinoid O-1602 increases hind paw sensitisation in the chronic constriction injury model of neuropathic pain.                                                             (abst – 2012)


Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells.                                                               (abst – 2012)


Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain. (abst – 2012)                         


Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system  (abst – 2012)









Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors.       (abst – 2012)                    


Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes.                                             (abst – 2012) 


Prevention of Paclitaxel-Induced Neuropathy Through Activation of the Central Cannabinoid Type 2 Receptor System                                                                   (abst – 2012)

http://www.anesthesia-  noid&searchid=1&FIRSTINDEX=130&sortspec=date&resourcetype=HWCIT


A Randomized, Double-Blind, Placebo Controlled, Parallel Assignment, Flexible Dose, Efficacy Study of Nabilone as Adjuvant in the Treatment of Diabetic Peripheral Neuropathic Pain Using an Enriched Enrollment Randomized Withdrawal Design (S38.003)           (abst – 2012)  s=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=180&sortspec=date&reso  urcetype=HWCIT


The Novel Reversible Fatty Acid Amide Hydrolase Inhibitor ST4070 Increases Endocannabinoid Brain Levels and Counteracts Neuropathic Pain in Different Animal Models (abst – 2012)


An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo- controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain.                                                                           (abst – 2012)


Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats. (abst – 2012) 


The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB2 receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy.                                                                                          (abst – 2012)


A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis.                                                                                                (abst – 2012)


The therapeutic potential of cannabis and cannabinoids.                 (abst – 2012)


Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: Effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide


hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment.                                             (abst – 2012)


Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma.                                                                        (abst – 2012)


Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain.            (abst – 2012)


Prevention of paclitaxel-induced neuropathy through activation of the central cannabinoid type 2 receptor system.                                                                              (abst – 2012)


California pot research backs therapeutic claims                 (news – 2012)


Cannabis as Painkiller                  (news – 2012)


Study: Synthetic THC Analogue Mitigates Diabetic Neuropathy, Is ‘Well Tolerated’ In Patients   (news – 2012)  tolerated-in-patients


New drug offers novel pain management therapy for diabetics.               (news – 2012)  a0306899453


Synthetic cannabinoid could treat pain in diabetes patients                (news – 2012) patients_.html


Drug offers new pain management therapy for diabetics              (news – 2012)


The role of endocannabinoids in pain modulation.               (full – 2013)


Drug design for neuropathic pain regulation from traditional chinese medicine. (abst – 2013)                        


Study: Vaporized, Low-Potency Cannabis Mitigates Neuropathic Pain             (news – 2013)


Palmitoylethanolamide reduces formalin-induced neuropathic-like behaviour through spinal glial/microglial phenotypical changes in mice.                                                        (abst – 2013)

Share a link for